Max India informs about disclosure

17 Dec 2019 Evaluate

With reference to earlier disclosure letter dated December 3, 2019, informing about receipt of requisite approval from Insurance Regulatory and Development Authority of India (IRDAI) for the divestment of entire shareholding of the Company held in its material subsidiary, Max Bupa Health Insurance Company (equivalent to 51% of Max Bupas total issued and paid-up equity share capital) to Fettle Tone LLP (an affiliate of True North Fund VI LLP); Max India has informed that post fulfillment of all conditions precedents, the Company has transferred its entire equity shareholding held in Max Bupa to Fettle Tone LLP on December 16, 2019. Further, Max India’s nominated directors on the Board of Max Bupa have resigned effective December 16, 2019. Consequently, Max Bupa Health Insurance Company ceased to be a subsidiary of the Company effective from December 16, 2019.

The above information is a part of company’s filings submitted to BSE.

Max India-Amalgamat. Share Price

68.65 0.00 (0.00%)
11-Jun-2020 18:01 View Price Chart
Peers
Company Name CMP
Bajaj Finserv 1559.80
Paul Merchants 938.05
IIFL Finance 409.55
Altius Telecom Infra 150.00
Embassy Office Parks 373.87
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.